In May 2026, the UK’s National Health Service (NHS) began a historic rollout of a new cancer treatment that is as stunning in its speed as it is in its potential reach. This is an injectable form of the immunotherapy drug pembrolizumab (Keytruda), capable of treating 14 different types of cancer with a jab that takes as little as 60 seconds.










